We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORE
1501
DELISTED
Monogram Residential Trust, Inc.
MORE
$216K 0.01%
22,056
+11,479
+109% +$113K
OHI icon
1502
Omega Healthcare
OHI
$15.4B
$215K 0.01%
6,164
-3,867
-39% -$134K
VASC
1503
DELISTED
Vascular Solutions Inc
VASC
$215K 0.01%
+6,251
New +$212K
WNC icon
1504
Wabash National
WNC
$541M
$214K 0.01%
18,098
-41,111
-69% -$486K
PBCT
1505
DELISTED
People's United Financial Inc
PBCT
$214K 0.01%
+13,259
New +$216K
FCF icon
1506
First Commonwealth Financial
FCF
$2.17B
$213K 0.01%
+23,537
New +$220K
FHN icon
1507
First Horizon
FHN
$12.3B
$213K 0.01%
+14,702
New +$213K
RRGB icon
1508
Red Robin
RRGB
$139M
$213K 0.01%
+3,462
New +$243K
JOYY
1509
JOYY Inc
JOYY
$3.77B
$213K 0.01%
+3,403
New +$202K
XENT
1510
DELISTED
Intersect ENT, Inc
XENT
$213K 0.01%
+9,485
New +$188K
AIT icon
1511
Applied Industrial Technologies
AIT
$12.9B
$212K 0.01%
+5,241
New +$214K
ALE
1512
DELISTED
Allete
ALE
$212K 0.01%
+4,178
New +$212K
XLE icon
1513
PUT
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$212K 0.01%
7,000
-1,338,600
-99% -$44.1M
BSFT
1514
DELISTED
BroadSoft, Inc.
BSFT
$212K 0.01%
+5,987
New +$211K
APLE icon
1515
Apple Hospitality REIT
APLE
$3.97B
$211K 0.01%
+10,572
New +$208K
CNO icon
1516
CNO Financial Group
CNO
$5B
$211K 0.01%
+11,038
New +$214K
NBTB icon
1517
NBT Bancorp
NBTB
$2.79B
$211K 0.01%
+7,571
New +$215K
CVA
1518
DELISTED
Covanta Holding Corporation
CVA
$211K 0.01%
+13,616
New +$223K
BBN icon
1519
BlackRock Taxable Municipal Bond Trust
BBN
$978M
$210K 0.01%
10,000
-33,543
-77% -$687K
EWG icon
1520
PUT
iShares MSCI Germany ETF
EWG
$1.56B
$210K 0.01%
+8,000
New +$212K
PLAB icon
1521
Photronics
PLAB
$1.72B
$210K 0.01%
+16,881
New +$181K
LNN icon
1522
Lindsay Corp
LNN
$1.17B
$209K 0.01%
+2,881
New +$199K
BP icon
1523
BP
BP
$107B
$208K 0.01%
+7,920
New +$225K
DHIL
1524
DELISTED
Diamond Hill
DHIL
$208K 0.01%
+1,100
New +$220K
RHP icon
1525
Ryman Hospitality Properties
RHP
$8.58B
$208K 0.01%
+4,026
New +$215K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.